HUDDINGE, Sweden--(BUSINESS WIRE)-- Regulatory News: Medivir AB (OMX: MVIR), an emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces that the board has appointed Maris Hartmanis as new President and CEO. Maris Hartmanis replaces Ron Long, who has been President and CEO of Medivir since 2009. Under Ron Longs leadership, the company has...
...